Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05742178 · ClinicalTrials.gov registry record · NA
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
A NA study of Cancer Screening, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 2,160
- Enrollment target
- 2
- Study locations
NCT05742178: Recruiting NA study of Cancer Screening, sponsored by NYU Langone Health.
NCT05742178 is a NA study of Cancer Screening that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 2,160 participants, above the 147-participant average among 4 other Cancer Screening trials with a reported enrollment target (1369% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05742178, a NA study of Cancer Screening, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,160 participants
- Enrollment target
- 2
- Study locations
Study Summary
NYC CONNECT will carry out a randomized controlled trial (RCT) which will assess the relative effectiveness of two evidence-based strategies to increase cancer screening rates for breast, cervical, and colorectal cancer. The RCT will compare the effectiveness of using a combination of 1) culturally and linguistically tailored cancer education materials and 2) community health workers (CHWs) to provide navigation services for cancer screening (the "patient navigation" \[PN\] arm) versus providing culturally and linguistically tailored cancer education only (the "less intensive" \[LI\] arm). The study population will include individuals who are due for breast, cervical, or colorectal cancer screening. All individuals recruited to the study will be provided navigation for unmet social determinants of health (SDH) needs.
Primary Outcome
Cancer screening defined as a breast, cervical, or colorectal cancer screening.
Conditions Studied
Interventions
- BEHAVIORAL Educational Materials
- BEHAVIORAL Patient Navigation (PN) - More Intensive
- BEHAVIORAL Patient Navigation (PN) - Less Intensive
Study Locations (2)
New York
- NYU Langone Health - New York
- Albert Einstein College of Medicine - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,160 participants |
| Start Date | 2023-07-05 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
What NCT05742178 shows while recruiting
NCT05742178 is an interventional study that assigns participants to a tested intervention. Its 2,160 participants enrollment target places it among the larger protocols in the corpus, above the 147-participant average among 4 other Cancer Screening trials with a reported enrollment target (1369% higher).
The record links to 1 condition, with Cancer Screening appearing as the primary indexed condition, and to 3 interventions - of which Educational Materials is the first listed.
NCT05742178 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05742178 about?
NCT05742178 is a clinical study titled "NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation". NYC CONNECT will carry out a randomized controlled trial (RCT) which will assess the relative effectiveness of two evidence-based strategies to increase cancer screening rates for breast, cervical, and colorectal cancer. The RCT will compare the effectiveness of using a combination of 1) culturally ...
What is the current status of trial NCT05742178?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,160 participants. The study started on 2023-07-05. Estimated completion is 2026-10-01.
What conditions does trial NCT05742178 study?
This clinical trial studies the following conditions: Cancer Screening.
What interventions are being tested in trial NCT05742178?
The interventions under investigation include: Educational Materials (BEHAVIORAL), Patient Navigation (PN) - More Intensive (BEHAVIORAL), Patient Navigation (PN) - Less Intensive (BEHAVIORAL).
Who is sponsoring clinical trial NCT05742178?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05742178 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
RECRUITING · NA
-
Participatory Approaches to Qualitative Research (PAQ): Comparing Two Approaches to Patient, Public and Clinician Involvement in Qualitative Research
RECRUITING · NA
-
Discussing Stopping Cancer Screening and Prognosis With Older Adults
COMPLETED · NA
-
Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06783335 · 2,150 participants
Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure
- NCT05805709 · 2,145 participants · NA
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
- NCT06598475 · 2,142 participants · NA
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
- NCT03488693 · 2,140 participants · Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI